RegistryReach
What the industry-payment data shows.
Data stories built from the federal Open Payments database and the national provider registry. Every number below is public record; we just do the joins.
Where the drug and device money moved in 2025
General payments grew a calm 5.5% to $2.89 billion, but the growth wasn't even: urology jumped 66%, radiology 36%, and the Internal Medicine family added $148M, while orthopaedics and pediatrics shrank. The year-over-year movers, and the pattern behind them.
Read the story →The per-provider money map: why Minnesota leads
Rank states by payments per paid provider and the map inverts: Minnesota leads at $6,019, Texas falls to 19th, and 45 percent of the winner's total went to 406 orthopaedic surgeons. The full top ten, and what the flip tells you about where industry attention concentrates.
Read the story →Who paid U.S. physicians the most in 2025: the manufacturer league table
Drug and device makers reported $2.89 billion in general payments to 1,020,608 providers in 2025. One company out-paid every drugmaker, and the top of the table isn't pharma at all. Here's the top ten, and what the mix says about where industry attention actually goes.
Read the story →